APA (7th ed.) Citation

ND, M., AY, A., NM, K., LX, L., GH, L., B, K., . . . AM, H. (2025). Associations of Commonly Used Concomitant Medications With Survival and Adverse Event Outcomes in Breast Cancer. Cancer medicine, 14(21), e71320. https://doi.org/10.1002/cam4.71320

Chicago Style (17th ed.) Citation

ND, Modi, et al. "Associations of Commonly Used Concomitant Medications With Survival and Adverse Event Outcomes in Breast Cancer." Cancer Medicine 14, no. 21 (2025): e71320. https://doi.org/10.1002/cam4.71320.

MLA (9th ed.) Citation

ND, Modi, et al. "Associations of Commonly Used Concomitant Medications With Survival and Adverse Event Outcomes in Breast Cancer." Cancer Medicine, vol. 14, no. 21, 2025, p. e71320, https://doi.org/10.1002/cam4.71320.